about
Melanized fungi in human diseaseBlack yeasts and their filamentous relatives: principles of pathogenesis and host defenseIn vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea sppChromoblastomycosis: study of 27 cases and review of medical literature.Sixty-year-old man with slowly expanding nodular plaque on the thighChromoblastomycosis.Structure, cellular distribution, antigenicity, and biological functions of Fonsecaea pedrosoi ceramide monohexosides.Photodynamic therapy combined with terbinafine against chromoblastomycosis and the effect of PDT on Fonsecaea monophora in vitro.Biology and pathogenesis of Fonsecaea pedrosoi, the major etiologic agent of chromoblastomycosis.Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment.Managing chromoblastomycosis.Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment.Challenges in the therapy of chromoblastomycosis.Chromoblastomycosis by Cladophialophora carrionii associated with squamous cell carcinoma and review of published reports.Treatment of severe chromoblastomycosis with itraconazole and 5-flucytosine association.Subcutaneous mycoses in coastal Karnataka in south India.Hidden under a Cauliflower-Like Skin Tumor: Chromoblastomycosis.A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy.A case of relapsed chromoblastomycosis due to Fonsecaea monophora: antifungal susceptibility and phylogenetic analysis.In vitro activity of antifungal drugs against Cladophialophora species associated with human chromoblastomycosis.Combination of amphotericin B and terbinafine against melanized fungi associated with chromoblastomycosis.Cutaneous infection by Phomopsis longicolla in a renal transplant recipient from Guinea: first report of human infection by this fungus.Cryosurgery for the treatment of cutaneous sporotrichosis in four pregnant women.Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment updateChromoblastomycosis
P2860
Q24633163-2102A448-A2AD-4044-AD0C-117575582135Q27028032-FCBEFCB9-781E-4066-AAAA-93D12AE74299Q33525228-89CD746A-D18B-44A4-BE15-D79939ACBE00Q34024300-A03C394B-0C6D-4C30-B253-C5BD4A54B9CBQ34362577-763441FC-9D81-4BA9-9F57-CB7D390E169CQ34457920-6672F6C9-F405-48DC-8396-36882556B850Q34469047-9FAF333F-51BE-44C6-A5C4-A5E10364E866Q35070221-5A1CBC03-B777-4909-84A2-E13BB0BE50DAQ36889096-0C4BFE24-222F-4B09-80EB-B179134EBFC3Q37351604-F84E0E13-502B-490A-9538-0E84538570B5Q37715591-F222D517-70AC-4BCB-B4BB-97628E55A5F1Q37815477-8F94FF71-B738-41C1-8B56-A048B85F3E1DQ38103473-DFA29EA0-A3FA-466F-9AD5-4E3D7AC40A7CQ38262598-44982F2F-495A-4010-A62A-9D2F5CF44274Q38876936-9F930FB6-31E1-47F7-A721-64F794E1AEC9Q38907686-39157489-4675-4169-B81F-8D5C2FDF8787Q39099710-B98D367B-AD33-4E32-BD93-F0F37924ECA5Q39613867-B6978B06-4ED0-4DF6-96B9-18BE8E686FE6Q43879952-B8616FD2-29EF-4856-978D-C2EF7982B2ECQ46179848-08F0E02F-9626-493D-B6FC-5B180F3BED94Q51148946-C2536915-9C45-4CDB-AF33-0159EF32B776Q51482709-2180A45A-62E7-4E4E-A930-899475260897Q55019924-784B02E9-15EA-45E9-82B1-2DCA6E801FA7Q56566535-CDCB5B86-2298-4656-8C69-6DCDBD3061B0Q56915677-C6C5F9D0-4929-4996-853C-003309557523
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Treating chromoblastomycosis with systemic antifungals.
@ast
Treating chromoblastomycosis with systemic antifungals.
@en
type
label
Treating chromoblastomycosis with systemic antifungals.
@ast
Treating chromoblastomycosis with systemic antifungals.
@en
prefLabel
Treating chromoblastomycosis with systemic antifungals.
@ast
Treating chromoblastomycosis with systemic antifungals.
@en
P2093
P2860
P356
P1476
Treating chromoblastomycosis with systemic antifungals.
@en
P2093
Alexandro Bonifaz
Amado Saúl
Vanessa Paredes-Solís
P2860
P304
P356
10.1517/14656566.5.2.247
P407
P577
2004-02-01T00:00:00Z